Pancreatic Neoplasm
Conditions
Keywords
pancreatogenic, diabetes, artificial, pancreas
Brief summary
This study evaluated a closed-loop system providing continuous monitoring and strict control of perioperative blood glucose following pancreatic resection.
Detailed description
This study recruited 32 patients undergoing elective pancreatic resection for pancreatic disease.
Interventions
DEVICEArtificial Pancreas (STG-22)
safe tool
Sponsors
Kochi University
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* This study recruited 32 patients undergoing elective pancreatic resection for pancreatic disease.
Exclusion criteria
* weight loss greater than 10% during the previous 6 months * signs of distant metastasis * respiratory, renal,or heart disease * Patients provided written informed consent prior to enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the incidence of severe hypoglycemia (< 40 mg/dl) during the intensive care period following pancreatic resection in patients monitored using the artificial pancreas | the first postoperative 18 hours in the surgical intensive care unit |
Secondary
| Measure | Time frame |
|---|---|
| the total amount of insulin required for glycemic control after pancreatic resection | the first postoperative 18 hours in the surgical intensive care unit |
Countries
Japan
Outcome results
None listed